SHEREX FASTENING SOLUTIONS LLC – Trademark Portfolio
Entity Type: 16
SHEREX FASTENING SOLUTIONS LLC holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 6 (Metal Goods) — 7 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 2 Nice Classification classes. Currently, 7 trademarks are registered. Notable registered marks include SX, SHEREX, LOCSERT, OPTISERT, and RIV-FLOAT. The owner is based in TONAWANDA, NY.
400 RIVERWALK PARKWAY
SUITE 600
TONAWANDA, NY 14150
Showing of trademarks Trademarks
Trademark Classifications
SHEREX FASTENING SOLUTIONS LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Common metals and their alloys; metal building materials; transportable buildings of metal
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does SHEREX FASTENING SOLUTIONS LLC have?
SHEREX FASTENING SOLUTIONS LLC has 8 U.S. trademarks filed with the USPTO. Of these, 7 registered, 1 cancelled.
What trademark classes does SHEREX FASTENING SOLUTIONS LLC file in?
SHEREX FASTENING SOLUTIONS LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 6 (Metal Goods), Class 35 (Advertising & Business). Class 6 covers common metals and their alloys; metal building materials; transportable buildings of metal.
What are SHEREX FASTENING SOLUTIONS LLC's most well-known trademarks?
SHEREX FASTENING SOLUTIONS LLC's registered trademark portfolio includes well-known marks such as SX, SHEREX, LOCSERT, OPTISERT, and RIV-FLOAT. These are among 7 currently registered trademarks in the portfolio.
What is SHEREX FASTENING SOLUTIONS LLC's trademark registration success rate?
SHEREX FASTENING SOLUTIONS LLC has a 88% trademark registration rate, with 7 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.